-
Rigel Pharmaceuticals (NASDAQ:RIGL) Lowered to "Buy" Rating by StockNews.com
Source: Buzz FX / 28 Feb 2025 22:16:14 America/New_York
Rigel Pharmaceuticals (NASDAQ:RIGL) Lowered to "Buy" Rating by StockNews.com Written by MarketBeat February 28, 2025 Share Link copied to clipboard. Rigel Pharmaceuticals ( NASDAQ:RIGL - Get Free Report ) was downgraded by research analysts
Read more...